Management of papillary thyroid cancer

Despite an excellent prognosis (99% survival rate at 20 years),  sub-clinical, small, low risk papillary thyroid cancers are often treated aggressively. This review offers an evidence based approach to managing these tumours and looks at the future of alternative surgical techniques and minimally localized invasive therapies such as ethanol ablation and laser ablation.

Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ 2014;348:g3045 doi:10.1136/bmj.g3045

NWES 2014: Friday 27 June

THE NORTH WEST ENDOCRINE SOCIETY
announces its next meeting
on
FRIDAY 27th June 2014, 13:00 – 17:40

VENUE
Seminar rooms 5&6
Mayo Building
Salford Royal Hospital, Stott Lane, Salford

PROGRAMME

NWES 2014 meeting flyer

 

Please note there is a SpR teaching half-day in the morning:

Final Programme SpR teaching day 27th June 2014

09:00 – 09:20         Registrations/coffee

09:20 – 10:00         Fertility issues in endocrinology –David Polson, Consultant Obstetrician & Gynaecologist, Salford Royal Hospital

10:00 – 10:40         Transitional endocrinology A to Z of puberty induction – Indie Banerjee, Consultant Paediatric Endocrinologist, Royal Manchester Children’s Hospital

10:40 – 11:00         Coffee break

11:00 – 11:40         CFS diagnostics, what lies beneath – Annice Mukherjee, Consultant Endocrinologist, Salford Royal Hospital

11:40 – 12:40         Cases (3 case presentations of 20 minutes each)

12:40 – 13:30         Lunch

13:30 – 17:40         NWES (see separate programme above)